Advanced search
Publication Cover
Future Science OA Volume 1, 2015 - Issue 1
Submit an article Journal homepage
5,880
Views
16
CrossRef citations to date
0
Altmetric
Special Report

Development and Therapeutic Applications of Nitric Oxide Releasing Materials to Treat Erectile Dysfunction

Kelvin P Davies1 Professor of Urology, Professor of Physiology & Biophysics, Albert Einstein College of Medicine, Forchheimer 742, 1300 Morris Park Ave, Bronx, NY10461, USACorrespondence[email protected]
View further author information
Article: FSO53 | Published online: 27 Jul 2015

References

  • Shamloul R , GhanemH. Erectile dysfunction. Lancet381(9861), 153–165 (2013).
  • Shabsigh R , AnastasiadisAG. Erectile dysfunction. Annu. Rev. Med.54, 153–168 (2003).
  • Mallis D , MoisidisK, KiranaPS, PapaharitouS, SimosG, HatzichristouD. Moderate and severe erectile dysfunction equally affects life satisfaction. J. Sex. Med.3(3), 442–449 (2006).
  • Burnett AL . Nitric oxide in the penis – science and therapeutic implications from erectile dysfunction to priapism. J. Sex. Med.3(4), 578–582 (2006).
  • Andersson KE , WagnerG. Physiology of penile erection. Physiol. Rev.75(1), 191–236 (1995).
  • Andersson KE . Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J. Urol.170(2 Pt 2), S6–S13; discussion S13–S14 (2003).
  • Hurt KJ , MusickiB, PaleseMAet al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc. Natl Acad. Sci. USA99(6), 4061–4066 (2002).
  • Burnett AL , ChangAG, CroneJK, HuangPL, SezenSE. Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase. J. Androl.23(1), 92–97 (2002).
  • Feelisch M , FernandezBO, BryanNSet al. Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J. Biol. Chem.283(49), 33927–33934 (2008).
  • Brioni JD , NakaneM, HsiehGC, MorelandRB, KolasaT, SullivanJP. Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction. Int. J. Impot. Res.14(1), 8–14 (2002).
  • Klotz T , MathersMJ, BraunM, BlochW, EngelmannU. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol. Int.63(4), 220–223 (1999).
  • Neuzillet Y , HupertanV, CourF, BottoH, LebretT. A randomized, double-blind, crossover, placebo-controlled comparative clinical trial of arginine aspartate plus adenosine monophosphate for the intermittent treatment of male erectile dysfunction. Andrology1(2), 223–228 (2013).
  • Shiota A , HottaY, KataokaT, MoritaM, MaedaY, KimuraK. Oral L-citrulline supplementation improves erectile function in rats with acute arteriogenic erectile dysfunction. J. Sex. Med.10(10), 2423–2429 (2013).
  • Cormio L , De SiatiM, LorussoFet al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology77(1), 119–122 (2011).
  • Bivalacqua TJ , UstaMF, ChampionHCet al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J. Urol.169(5), 1911–1917 (2003).
  • Champion HC , BivalacquaTJ, HymanAL, IgnarroLJ, HellstromWJ, KadowitzPJ. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc. Natl Acad. Sci. USA96(20), 11648–11652 (1999).
  • Magee TR , KovaneczI, DavilaHHet al. Antisense and short hairpin RNA (shRNA) constructs targeting PIN (protein inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat. J. Sex. Med.4(3), 633–643 (2007).
  • Melman A , Bar-ChamaN, McCulloughA, DaviesK, ChristG. hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum. Gene Ther.17(12), 1165–1176 (2006).
  • Burnett AL , BivalacquaTJ, ChampionHC, MusickiB. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J. Sex. Med.3(6), 1077–1084 (2006).
  • Burnett AL , MusickiB, JinL, BivalacquaTJ. Nitric oxide/redox-based signalling as a therapeutic target for penile disorders. Expert Opin. Ther. Targets10(3), 445–457 (2006).
  • Nunez BD , AndersonDCJr. Nitroglycerin ointment in the treatment of impotence. J. Urol.150(4), 1241–1243 (1993).
  • Lagoda G , SezenSF, HurtKJ, CabriniMR, MohantyDK, BurnettAL. Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J.28(1), 76–84 (2014).
  • Soni SD , SongW, WestJL, KheraM. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J. Sex. Med.10(8), 1915–1925 (2013).
  • Han G , TarM, KuppamDSet al. Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J. Sex. Med.7(1 Pt 1), 224–233 (2010).
  • Tar M , CabralesP, NavatiMet al. Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J. Sex. Med.11(12), 2903–2914 (2014).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.